The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Extracellular Alpha-Synuclein Oligomers Modulate Synaptic Transmission and Impair LTP Via NMDA-Receptor Activation
Open accessAbstract
Parkinson's disease (PD) is the most common representative of a group of disorders known as synucleinopathies, in which misfolding and aggregation of α-synuclein (a-syn) in various brain regions is the major pathological hallmark. Indeed, the motor symptoms in PD are caused by a heterogeneous degeneration of brain neurons not only in substantia nigra pars compacta but also in other extrastriatal areas of the brain. In addition to the well known motor dysfunction in PD patients, cognitive deficits and memory impairment are also an important part of the disorder, probably due to disruption of synaptic transmission and plasticity in extrastriatal areas, including the hippocampus. Here, we investigated the impact of a-syn aggregation on AMPA and NMDA receptor-mediated rat hippocampal (CA3-CA1) synaptic transmission and long-term potentiation (LTP), the neurophysiological basis for learning and memory. Our data show that prolonged exposure to a-syn oligomers, but not monomers or fibrils, increases basal synaptic transmission through NMDA receptor activation, triggering enhanced contribution of calcium-permeable AMPA receptors. Slices treated with a-syn oligomers were unable to respond with further potentiation to theta-burst stimulation, leading to impaired LTP. Prior delivery of a low-frequency train reinstated the ability to express LTP, implying that exposure to a-syn oligomers drives the increase of glutamatergic synaptic transmission, preventing further potentiation by physiological stimuli. Our novel findings provide mechanistic insight on how a-syn oligomers may trigger neuronal dysfunction and toxicity in PD and other synucleinopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abràmoff, M. D., Magalhães, P. J., & Ram, S. J. (2004) · Utrecht University Repository (Utrecht University) · Cited by 15,104
A synaptic model of memory: long-term potentiation in the hippocampus
Bliss, T. V. P., & Collingridge, G. L. (1993) · Nature · doi:10.1038/361031a0 · Cited by 11,566 · cited 6×
“…HNE-oligomers (see above), they might be involved downstream in the cascade of injury induction. a-syn HNE-oligomers alter AMPA receptor subunit composition Changes in synaptic efficiency and plasticity also rely upon tuning of the synaptic AMPA receptor component (Bliss and Collingridge, 1993).”
BackgroundInfluentialSpillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Parkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720 · cited 1×
“Parkinson s disease (PD) is typically known for the loss of nigrostriatal dopaminergic neurons associated with motor impairment, of which muscle rigidity, resting tremor, bradykinesia, and postural instability are the cardinal symptoms (Jankovic, 2008).”
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Morris, R. G. M., Anderson, E., Lynch, G. S., & Baudry, M. (1986) · Nature · doi:10.1038/319774a0 · Cited by 3,640 · cited 1×
“To investigate whether exacerbation of NMDA receptor function was involved in the effect of a-syn oligomeric species on LTP, slices were preincubated for 90 min with an NMDA receptor antagonist, APV (50 M) (Morris et al., 1986), in the presence or in the absence of a-syn oligomers.”
Synaptic Plasticity and Memory: An Evaluation of the Hypothesis
Martin, S. J., Grimwood, P. D., & Morris, R. G. M. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.649 · Cited by 2,794 · cited 1×
“…is critical for determining the expression level and composition of AMPA receptors at the postsynaptic membrane (Bliss and Collingridge, 1993; Martin et al., 2000; Collingridge et al., 2004), through which significant alterations of synaptic transmission and plasticity are achieved (Plant et…”
BackgroundStages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,658
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,132
Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845
Rapid Spine Delivery and Redistribution of AMPA Receptors After Synaptic NMDA Receptor Activation
Shi, S.-H., Hayashi, Y., Petralia, R. S., Zaman, S. H., Wenthold, R. J., Svoboda, K., & Malinow, R. (1999) · Science · doi:10.1126/science.284.5421.1811 · Cited by 1,276
Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease
Auluck, P. K., Chan, H. Y. E., Trojanowski, J. Q., Lee, V. M.-Y., & Bonini, N. M. (2002) · Science · doi:10.1126/science.1067389 · Cited by 1,227 · cited 1×
“These inclusions are mainly composed of -synuclein (a-syn), a neuronal presynaptic protein implicated in vesicular trafficking, neurotransmitter release, and regulation of neurotransmission (Clayton and George, 1999; Auluck et al., 2002; Fujiwara et al., 2002).”
BackgroundRegulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity
Lee, H.-K., Barbarosie, M., Kameyama, K., Bear, M. F., & Huganir, R. L. (2000) · Nature · doi:10.1038/35016089 · Cited by 1,116 · cited 1×
“…plasticity, namely with the ability for both theta-burst stimulation and LFS to affect the phosphorylation status and membrane levels of GluR1-containing AMPA receptors (Lee et al., 2000) and point toward involvement of AMPA receptors in the synaptic dysfunctions induced by a-syn HNE-oligomers.”
Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation
Uversky, V. N., Li, J., & Fink, A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010907200 · Cited by 1,096 · cited 1×
“This protein is known to undergo misfolding and oligomerization, under specific conditions, forming dimers, oligomers, and fibrillar structures (Conway et al., 2000; Uversky et al., 2001; Lashuel et al., 2002).”
BackgroundSirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease
Outeiro, T. F., Kontopoulos, E., Altmann, S. M., Kufareva, I., Strathearn, K. E., Amore, A. M., Volk, C. B., Maxwell, M. M., Rochet, J.-C., McLean, P. J., et al. (2007) · Science · doi:10.1126/science.1143780 · Cited by 1,062
Self-citationReceptor trafficking and synaptic plasticity
Collingridge, G. L., Isaac, J. T. R., & Wang, Y. T. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1556 · Cited by 1,046
Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Selkoe, D. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.016 · Cited by 1,038
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.
Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981
Techniques to study amyloid fibril formation in vitro
NILSSON, M. (2004) · Methods · doi:10.1016/j.ymeth.2004.03.012 · Cited by 948
Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons
Wenthold, R., Petralia, R., Blahos J, II, & Niedzielski, A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-06-01982.1996 · Cited by 850
Hansen, C., Angot, E., Bergström, A.-L., Steiner, J. A., Pieri, L., Paul, G., Outeiro, T. F., Melki, R., Kallunki, P., Fog, K., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43366 · Cited by 842
Self-citationLashuel, H. A., Petre, B. M., Wall, J., Simon, M., Nowak, R. J., Walz, T., & Lansbury, P. T. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00735-0 · Cited by 805
Intravesicular Localization and Exocytosis of α-Synuclein and its Aggregates
Lee, H.-J., Patel, S., & Lee, S.-J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0692-05.2005 · Cited by 797
Conway, K. A., Harper, J. D., & Lansbury, P. T. (2000) · Biochemistry · doi:10.1021/bi991447r · Cited by 786
The Role of Excitotoxicity in Neurodegenerative Disease
Doble, A. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00042-4 · Cited by 723
THE BIOCHEMISTRY OF PARKINSON'S DISEASE
Cookson, M. R. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133400 · Cited by 664
Townsend, M., Shankar, G. M., Mehta, T., Walsh, D. M., & Selkoe, D. J. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.103754 · Cited by 619
El-Agnaf, O. M. A., Salem, S. A., Paleologou, K. E., Cooper, L. J., Fullwood, N. J., Gibson, M. J., Curran, M. D., Court, J. A., Mann, D. M. A., Ikeda, S.-I., et al. (2003) · The FASEB Journal · doi:10.1096/fj.03-0098fje · Cited by 590
Unraveling mechanisms of homeostatic synaptic plasticity
Pozo, K., & Goda, Y. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.028 · Cited by 565
Plant, K., Pelkey, K. A., Bortolotto, Z. A., Morita, D., Terashima, A., McBain, C. J., Collingridge, G. L., & Isaac, J. T. R. (2006) · Nature Neuroscience · doi:10.1038/nn1678 · Cited by 542
Synucleins in synaptic plasticity and neurodegenerative disorders
Clayton, D. F., & George, J. M. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991001)58:1<120::aid-jnr12>3.0.co;2-e · Cited by 442
β-Amyloid Monomers Are Neuroprotective
Giuffrida, M. L., Caraci, F., Pignataro, B., Cataldo, S., De Bona, P., Bruno, V., Molinaro, G., Pappalardo, G., Messina, A., Palmigiano, A., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1736-09.2009 · Cited by 421
Anderson, W. W., & Collingridge, G. L. (2001) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(01)00374-0 · Cited by 416
Mattila, P. M., Rinne, J. O., Helenius, H., Dickson, D. W., Röyttä, M., & Mattila, P. M. (2000) · Acta Neuropathologica · doi:10.1007/s004019900168 · Cited by 361
Kelly, B. L., & Ferreira, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605081200 · Cited by 241
Rationale for and use of NMDA receptor antagonists in Parkinson's disease
Hallett, P. J., & Standaert, D. G. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.04.001 · Cited by 237
Besancon, E., Guo, S., Lok, J., Tymianski, M., & Lo, E. H. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.02.003 · Cited by 231
Donevan, S. D., & Rogawski, M. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9298 · Cited by 230
Guire, E. S., Oh, M. C., Soderling, T. R., & Derkach, V. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0384-08.2008 · Cited by 169
Friguet, B., Szweda, L. I., & Stadtman, E. R. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1222 · Cited by 169
Castellani, R. J., Perry, G., Siedlak, S. L., Nunomura, A., Shimohama, S., Zhang, J., Montine, T., Sayre, L. M., & Smith, M. A. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02514-9 · Cited by 169
Assessment of α-Synuclein Secretion in Mouse and Human Brain Parenchyma
Emmanouilidou, E., Elenis, D., Papasilekas, T., Stranjalis, G., Gerozissis, K., Ioannou, P. C., & Vekrellis, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022225 · Cited by 163 · cited 1×
“Western blot analysis revealed an enrichment in a-syn within the same range of that found in the CSF of the A53T versus WT mice (Emmanouilidou et al., 2011).”
BackgroundA subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors
Mullasseril, P., Hansen, K. B., Vance, K. M., Ogden, K. K., Yuan, H., Kurtkaya, N. L., Santangelo, R., Orr, A. G., Le, P., Vellano, K. M., et al. (2010) · Nature Communications · doi:10.1038/ncomms1085 · Cited by 158
The effects of temperature on synaptic transmission in hippocampal tissue slices
Schiff, S. J., & Somjen, G. G. (1985) · Brain Research · doi:10.1016/0006-8993(85)91004-2 · Cited by 146
The N-Terminal Repeat Domain of α-Synuclein Inhibits β-Sheet and Amyloid Fibril Formation
Kessler, J. C., Rochet, J., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi020429y · Cited by 146
Näsström, T., Fagerqvist, T., Barbu, M., Karlsson, M., Nikolajeff, F. K., Kasrayan, A., Ekberg, M., Lannfelt, L., Ingelsson, M., & Bergström, J. J. E. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.027 · Cited by 143
Self-citationEnhancement of LTP in Aged Rats is Dependent on Endogenous BDNF
Diógenes, M. J., Costenla, A. R., Lopes, L. V., Jerónimo-Santos, A., Sousa, V. C., Fontinha, B. M., Ribeiro, J. A., & Sebastião, A. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.64 · Cited by 139
Self-citationMiñano-Molina, A. J., España, J., Martín, E., Barneda‐Zahonero, B., Fadó, R., Solé, M., Trullás, R., Saura, C. A., & Rodríguez-Álvarez, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.227504 · Cited by 127
Martin, Z. S., Neugebauer, V., Dineley, K. T., Kayed, R., Zhang, W., Reese, L. C., & Taglialatela, G. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07576.x · Cited by 126
Genetics of Parkinson's disease and biochemical studies of implicated gene products
Lansbury, P. T., & Brice, A. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00302-7 · Cited by 120
Dias, R. B., Ribeiro, J. A., & Sebastião, A. M. (2010) · Hippocampus · doi:10.1002/hipo.20894 · Cited by 103
Self-citationNMDA Receptor Activation by Spontaneous Glutamatergic Neurotransmission
Espinosa, F., & Kavalali, E. T. (2009) · Journal of Neurophysiology · doi:10.1152/jn.90754.2008 · Cited by 83
Hüls, S., Högen, T., Vassallo, N., Danzer, K. M., Hengerer, B., Giese, A., & Herms, J. W. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07254.x · Cited by 81
McElligott, Z. A., Klug, J. R., Nobis, W. P., Patel, S., Grueter, B. A., Kash, T. L., & Winder, D. G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905568107 · Cited by 80
Turner, M. A., Moran, N. F., & Kopelman, M. D. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.180.2.148 · Cited by 72
Genetics of Parkinson's disease and biochemical studies of implicated gene products: Commentary
Lansbury, P. T., & Brice, A. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00377-0 · Cited by 67
Synthesis and in vitro evaluation of fluorinated styryl benzazoles as amyloid-probes
Morais, G. R., Miranda, H. V., Santos, I. C., Santos, I., Outeiro, T. F., & Paulo, A. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.09.065 · Cited by 34
Self-citationZhao, W., Wu, X., Xie, H., Ke, Y., & Yung, W. (2010) · Neurosignals · doi:10.1159/000324040 · Cited by 30
Cited by
Fricker, M., Tolkovsky, A. M., Borutaite, V., Coleman, M., & Brown, G. C. (2018) · Physiological Reviews · doi:10.1152/physrev.00011.2017 · Cited by 1,108
Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., et al. (2017) · Movement Disorders · doi:10.1002/mds.27115 · Cited by 859
Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
Gómez-Benito, M., Granado, N., García-Sanz, P., Michel, A., Dumoulin, M., & Moratalla, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00356 · Cited by 437
Glutamate-induced excitotoxicity in Parkinson's disease: The role of glial cells
Iovino, L., Tremblay, M. E., & Civiero, L. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.07.011 · Cited by 374
Alpha-Synuclein Oligomers—Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders
Ingelsson, M. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00408 · Cited by 344
Self-citation
Metadata
- Authors
- Diógenes, M. J., Dias, R. B., Rombo, D. M., Vicente Miranda, H., Maiolino, F., Guerreiro, P., Näsström, T., Franquelim, H. G., Oliveira, L. M. A., Castanho, M. A. R. B., Lannfelt, L., Bergström, J., Ingelsson, M., Quintas, A., Sebastião, A. M., Lopes, L. V., & Outeiro, T. F.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2012-08-22
- Volume
- 32
- Issue
- 34
- Pages
- 11750-11762
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2036203077
- Cited by
- 271
- References
- 59
- FWCI
- 8.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.